In-vitro diagnostic substance manufacturing (NAICS 325413) obligations

Five thousand six hundred eighty-three awards, $1.88 billion

The $1,876,000,543.48 obligation stock sits on 5,683 contract awards, implying about $330,100 per award. IVD contracting can mix reagent vehicles with smaller kit orders. The packet does not split analytes. It supports the sum and the count.

Medical laboratories (621511) run tests; 325413 makes the substances used in tests. Those dollars are not inside this manufacturing total unless the award also carried 325413. Do not merge lab services and reagent manufacturing without citing both hubs.

Diagnostic manufacturing, not FDA 510(k) counts

USAspending.gov records obligations on awards. Device and IVD clearance databases record marketing authorizations. $1,876,000,543.48 is the first of those, filtered to NAICS 325413. It is not a count of cleared tests and not a safety grade.

Assistance for public-health preparedness may lack NAICS. Those grants would not increment this industry total. Keep 325413 on the contract hub.

Obligations versus reagent invoices

An IVD-supply contract can be obligated by delivery order while invoices follow shipment. Outlays are not in the packet. The 5,683 awards include modifications that keep 325413. Negative modifications reduce the net without meaning that a test was withdrawn.

What 5,683 does not count

The award count is not 5,683 kits and not 5,683 manufacturers. One reagent IDIQ can generate many of those rows. The industry page lists recipients.

Using the IVD-manufacturing hub

The In-Vitro Diagnostic Substance Manufacturing industry page lists the USAspending.gov actions behind $1.88 billion. Agencies and vendors belong there. Compare 325413 with medical laboratories and electromedical apparatus on the all-industries index.

Citing 325413 without mixing reagents and lab operations

Quote $1,876,000,543.48 as USAspending contract obligations on 5,683 awards tagged NAICS 325413. Do not fold in medical-laboratory services unless those awards also carry 325413. Making a diagnostic substance is easy to confuse with running the assay; the industry table follows the code on the award.

Readers sometimes treat IVD dollars as a proxy for tests performed. The public NAICS total does not support that conversion. The $1.88 billion is a contract-obligation stock. Delivery orders can raise the recorded commitment before kits ship. Keep outlays out of the sentence.

The 5,683-award count should travel with the dollars. Warehouse refreshes can move both figures. Recoding an order to pharmaceutical-preparation NAICS would send new actions off this page.

Assistance without NAICS remains outside. Quote USAspending.gov, quote obligations, quote 5,683 awards, and open the hub for recipients. Stop before converting in-vitro diagnostic substance manufacturing into clinical advice.

Readers quoting this industry should keep two packet facts in one sentence: $1,876,000,543 in USAspending.gov contract obligations and 5,683 awards tagged NAICS 325413 (IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING). Dropping either figure hides whether the book is a few large vehicles or many small orders. The rounded obligation used for citation is $1,876,000,543; cents on the source total, if any, do not change the industry identity of the code.

IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING shows 5,683 award records, enough to include recurring orders without resembling a micro-purchase flood. Modifications that keep the code are inside the count. Chemical and related manufacturing codes record tagged contract commitments, not pounds released and not FDA clearance counts. IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING is the NAICS filter, not a laboratory notebook. Record corrections in the USAspending.gov warehouse can move both the $1,876,000,543 and the 5,683-award count. Treat the live IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING industry page as current and this file as a reading of the harvested packet.

Internal comparison belongs on the all-industries index, where NAICS 325413 sits beside other six-digit contract totals. Adding neighboring codes by hand creates a new total this packet does not contain; cite each NAICS if you add. Assistance awards that omit NAICS remain outside $1,876,000,543. Outlays remain unpublished here. Quote obligations, quote 5,683 awards, cite USAspending.gov, and open the overlay hub for recipients rather than inventing agencies, fiscal years, or unit counts the packet does not list.

A second check on language: do not call $1,876,000,543 an appropriation, a budget request, or cash disbursed. It is the recorded contract-obligation stock for IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING (NAICS 325413) in the indexed USAspending.gov extract. Do not call 5,683 a count of establishments. It is an award-record count. Those two constraints are the whole method of this guide.

Questions

How much is obligated under NAICS 325413 IVD manufacturing?

USAspending.gov contract awards tagged In-Vitro Diagnostic Substance Manufacturing show $1,876,000,543.48 in obligations on 5,683 awards. That is a procurement commitment total, not a test-kit census and not outlays. USAspending.gov is the source for the $1,876,000,543 obligation stock and the 5,683 contract awards tagged IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING (NAICS 325413). Assistance awards that omit NAICS are outside both figures.

Is this the same as medical laboratory contracts?

No. Medical laboratories use NAICS 621511 when tagged that way. Only awards reported as 325413 feed the $1,876,000,543.48. Compare both hubs on the all-industries index. Keep the citation on contract obligations: $1,876,000,543 on 5,683 awards coded NAICS 325413. Outlays, grants without NAICS, and unit counts are not in the packet that produced this page.

Do 5,683 awards mean 5,683 diagnostic tests?

No. The 5,683 figure counts contract records, including orders and modifications that keep 325413. One vehicle can cover many line items. The industry page lists the records. The industry hub lists the underlying USAspending.gov rows. This answer restates only packet facts: NAICS 325413, $1,876,000,543 obligated, and 5,683 awards for IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING.

Are public-health grants included?

Assistance awards often lack NAICS, so they are omitted from this rollup. The $1,876,000,543.48 and 5,683 awards are the contract slice tagged 325413. Do not treat 5,683 as establishments or $1,876,000,543 as cash disbursed. Both numbers describe USAspending.gov contract actions tagged NAICS 325413 (IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING), not assistance and not outlays.